Similar Articles
1251 Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
1252 Criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation
1253 Model based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis
1254 Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation
1255 Chemotherapy for transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
1256 Current management of hepatocellular carcinoma
1257 Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma
1258 Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy
1259 Length of negative resection margin does not affect local recurrence and survival in the patients with gastric cancer
1260 Clinical outcome of small hepatocellular carcinoma after different treatments: A meta-analysis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA